Raven SR Competitors

Our way of life is built on carbon, from our fuel sources to the materials in our consumer products, but we need a more sustainable way to source it to protect the future of our planet. LanzaTech Global, Inc. is the carbon recycling company transforming waste carbon into sustainable raw materials for everyday products. Using its biorecycling technology, LanzaTech captures carbon-rich gases generated by energy-intensive industries at the source, preventing them from being emitted into the air. LanzaTech then gives that captured carbon a new life as a sustainable replacement for virgin fossil carbon in everything from household cleaners and clothing fibers to packaging and fuels. By partnering with companies across the global supply chain like ArcelorMittal, Zara, H&M Move and Coty, LanzaTech is paving the way for a circular carbon economy.

Newlight is a biotechnology company turning greenhouse gas into high-performance materials. Newlight was founded in 2003 with a question: why can't we use greenhouse gas as a source of good? Over two decades of research, Newlight developed a biotechnological process to produce a material called Aircarbon®: a polymer made from air and greenhouse gas. Today, Aircarbon is being used as a performance material in a variety of industries, from foodware to fashion. In recognition of Newlight's commercialization achievements, Newlight has been honored to be awarded: "Innovation of the Year" by Popular Science, "Technology Pioneer" by the World Economic Forum, "Technology Excellence Award" by PC Magazine, "Company of the Year" by CleanTech OC, and "Biomaterial of the Year" by the Nova-Institute. www.newlight.com www.aircarbon.com

UK Biobank is a large-scale biomedical database and research resource containing genetic, lifestyle and health information from half a million UK participants. UK Biobank’s database, which includes blood samples, heart and brain scans and genetic data of the 500,000 volunteer participants, is globally accessible to approved researchers who are undertaking health-related research that’s in the public interest. UK Biobank recruited 500,000 people aged between 40-69 years in 2006-2010 from across the UK. With their consent, they provided detailed information about their lifestyle, physical measures and had blood, urine and saliva sample collected and stored for future analysis. UK Biobank’s research resource is a major contributor in the advancement of modern medicine and treatment, enabling better understanding of the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses – including cancer, heart diseases and stroke. UK Biobank is generously supported by its founding funders the Wellcome Trust and UK Medical Research Council, as well as the Department of Health, Scottish Government, the Northwest Regional Development Agency, British Heart Foundation and Cancer Research UK. The organisation has over 150 dedicated members of staff, based in multiple locations across the UK.